Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 21 July, 2024
Author: Getaka|Social: Getaka Financial Services X (Earlier Twitter) Profile Getaka Financial Services LinkedIn Logo
Stock Ticker - BSE: 532067 | NSE: 3BBLACKBIO

Fundamental Analysis of 3B Blackbio DX Ltd

Basic Stock Data

Last Updated: July 19, 2024, 10:24 pm

Market Cap 884 Cr.
Current Price 1,030
High / Low1,274/420
Stock P/E27.5
Book Value 260
Dividend Yield0.24 %
ROCE21.0 %
ROE16.3 %
Face Value 10.0
PEG Ratio0.91

Data Source: screener.in

Competitors of 3B Blackbio DX Ltd

Stock NameMarket CapCurrent PriceHigh / LowStock P/EBook ValueDividend YieldROCEROEFace Value
Best Agrolife Ltd 1,403 Cr. 5931,374/45413.2 2740.51 %16.5 %18.1 % 10.0
Bhagiradha Chemicals & Industries Ltd 3,285 Cr. 264285/110162 31.90.04 %9.69 %6.27 % 1.00
Phyto Chem (India) Ltd 12.8 Cr. 29.855.6/27.9 17.10.00 %4.64 %37.1 % 10.0
UPL Ltd 40,728 Cr. 543639/448 3701.84 %3.31 %3.82 % 2.00
Bhaskar Agrochemicals Ltd 40.2 Cr. 77.2122/33.023.1 26.50.00 %14.7 %13.4 % 10.0
Industry Average10,158.70 Cr957.9442.54192.340.63%13.52%16.18%7.06

Quarterly Result

MonthMar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
Sales18.8832.6715.2214.3618.4011.6917.3114.7318.1114.2819.1817.6723.00
Expenses10.3714.469.227.3912.486.518.137.4210.657.8411.398.8013.12
Operating Profit8.5118.216.006.975.925.189.187.317.466.447.798.879.88
OPM %45.07%55.74%39.42%48.54%32.17%44.31%53.03%49.63%41.19%45.10%40.62%50.20%42.96%
Other Income1.191.551.941.541.871.241.962.881.152.962.752.634.19
Interest0.040.030.060.03-0.020.030.070.050.040.020.040.030.04
Depreciation0.110.150.180.170.170.170.240.250.210.190.240.320.30
Profit before tax9.5519.587.708.317.646.2210.839.898.369.1910.2611.1513.73
Tax %25.55%23.70%23.64%21.06%36.91%24.12%23.27%22.04%37.80%21.55%26.02%23.68%35.98%
Net Profit7.1014.945.886.564.824.728.317.725.197.217.588.518.79
EPS in Rs8.2417.536.857.665.535.3911.208.967.729.7110.4611.6111.81

Last Updated: July 11, 2024, 8:25 am

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: July 10, 2024, 11:32 pm

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Sales2022191716232329227816274
Expenses192118161418162077443341
Operating Profit11123579150372933
OPM %6%6%7%9%16%23%31%32%66%46%47%44%
Other Income0000001237713
Interest111111000000
Depreciation000000111111
Profit before tax100015710152433544
Tax %34%14%23%23%19%24%25%23%25%26%27%28%
Net Profit00001358114322632
EPS in Rs0.620.590.360.511.765.358.1810.24151.6642.8934.5538.13
Dividend Payout %0%0%0%0%17%9%6%7%6%24%7%0%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2017-20182018-20192019-20202020-20212021-20222022-20232023-2024
YoY Net Profit Growth (%)200.00%66.67%60.00%1325.00%-71.93%-18.75%23.08%
Change in YoY Net Profit Growth (%)0.00%-133.33%-6.67%1265.00%-1396.93%53.18%41.83%

Growth

Compounded Sales Growth
10 Years:13%
5 Years:26%
3 Years:-31%
TTM:20%
Compounded Profit Growth
10 Years:56%
5 Years:44%
3 Years:-34%
TTM:24%
Stock Price CAGR
10 Years:66%
5 Years:66%
3 Years:21%
1 Year:149%
Return on Equity
10 Years:33%
5 Years:35%
3 Years:18%
Last Year:16%

Last Updated: July 16, 2024, 4:55 pm

Balance Sheet

Last Updated: July 10, 2024, 11:32 pm

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Equity Capital666666677779
Reserves34445121625125146164214
Borrowings678896642321
Other Liabilities7776668959374124
Total Liabilities2324252426303645194192214248
Fixed Assets444334445787
CWIP000000000000
Investments00000001599392117
Other Assets192021212226324013093114123
Total Assets2324252426303645194192214248

Reserves and Borrowings Chart

Cash Flow

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Cash from Operating Activity -1001124798372327
Cash from Investing Activity 0-0-0-0-0-1-1-1-70-2812-20
Cash from Financing Activity -00-0-1-00-11-2-15-5-4
Net Cash Flow-10-00012726-6303

Free Cash Flow

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Free Cash Flow-5.00-6.00-7.00-6.00-6.00-1.001.005.00148.0034.0027.0032.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Debtor Days18022021326228332125929025256136200
Inventory Days109149120145143175
Days Payable165220189218203186
Cash Conversion Cycle12414914418822331025929025256136200
Working Capital Days16721421827431237730835130267169248
ROCE %7%8%7%7%7%13%24%28%31%162%27%19%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthJun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
Promoters38.35%38.35%38.43%38.43%38.43%38.43%38.43%38.43%38.43%38.43%38.43%41.29%
FIIs1.47%0.54%1.23%1.64%1.64%1.64%2.11%2.54%3.06%3.16%3.38%2.97%
DIIs0.09%0.08%0.08%0.08%0.08%0.00%0.00%0.00%0.00%0.82%1.18%1.89%
Public60.09%61.03%60.26%59.85%59.85%59.94%59.47%59.02%58.50%57.60%56.99%53.85%
No. of Shareholders10,54116,25116,75616,46816,31615,41513,79813,13612,41610,51310,0889,753

Shareholding Pattern Chart

No. of Shareholders

This stock is not held by any mutual fund

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 24Mar 23Mar 22Mar 21Mar 20
FaceValue10.0010.0010.0010.0010.00
Basic EPS (Rs.)37.4634.5543.40151.6610.25
Diluted EPS (Rs.)37.4634.5543.40151.6610.25
Cash EPS (Rs.)38.7035.7743.88152.8210.98
Book Value[Excl.RevalReserv]/Share (Rs.)263.15261.50229.69197.9245.73
Book Value[Incl.RevalReserv]/Share (Rs.)263.15261.50229.69197.9245.73
Revenue From Operations / Share (Rs.)86.5182.54107.65302.6638.54
PBDIT / Share (Rs.)53.1248.5558.73204.0714.57
PBIT / Share (Rs.)51.8847.4057.84203.2513.86
PBT / Share (Rs.)51.7447.1357.69202.9413.42
Net Profit / Share (Rs.)37.4634.6242.98152.0010.26
NP After MI And SOA / Share (Rs.)38.2034.6242.98152.0010.26
PBDIT Margin (%)61.4058.8154.5667.4237.80
PBIT Margin (%)59.9757.4253.7267.1535.95
PBT Margin (%)59.8057.1053.5967.0534.81
Net Profit Margin (%)43.3041.9439.9250.2126.62
NP After MI And SOA Margin (%)44.1641.9439.9250.2126.62
Return on Networth / Equity (%)14.6715.1421.0486.2323.93
Return on Capital Employeed (%)19.2817.7624.73101.1328.30
Return On Assets (%)13.1912.1116.7658.8317.14
Long Term Debt / Equity (X)0.000.010.010.010.04
Total Debt / Equity (X)0.000.010.010.010.10
Asset Turnover Ratio (%)0.320.300.130.380.41
Current Ratio (X)7.048.054.822.764.82
Quick Ratio (X)6.567.494.382.644.32
Inventory Turnover Ratio (X)2.412.332.662.682.48
Dividend Payout Ratio (NP) (%)0.000.000.000.0020.17
Dividend Payout Ratio (CP) (%)0.000.000.000.0018.85
Earning Retention Ratio (%)0.000.000.000.0079.83
Cash Earning Retention Ratio (%)0.000.000.000.0081.15
Interest Coverage Ratio (X)365.87183.32413.58669.5332.67
Interest Coverage Ratio (Post Tax) (X)259.05131.73303.65499.6823.99
Enterprise Value (Cr.)600.55278.94248.35196.4350.63
EV / Net Operating Revenue (X)8.104.513.080.861.75
EV / EBITDA (X)13.197.675.641.284.64
MarketCap / Net Operating Revenue (X)8.905.043.170.941.88
Retention Ratios (%)0.000.000.000.0079.82
Price / BV (X)2.961.821.671.621.69
Price / Net Operating Revenue (X)8.905.043.170.941.88
EarningsYield0.040.080.120.530.14

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value: 1,168.25

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

Undervalued: 13.42% compared to the current price 1030

Intrinsic Value: 1,519.60

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators along with EPS growth.

Undervalued: 47.53% compared to the current price 1030

Last 5 Year EPS CAGR: 30.07%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The stock has a high average ROCE of 28.33%, which is a positive sign.
  2. The company has higher reserves (60.17 cr) compared to borrowings (5.17 cr), indicating strong financial stability.
  3. The company has shown consistent growth in sales (51.08 cr) and profit (24.83 cr) over the years.
  1. The stock has a high average Working Capital Days of 250.58, which may not be favorable.
  2. The stock has a high average Cash Conversion Cycle of 194.25, which may not be favorable.

Stock Analysis

  • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in 3B Blackbio DX Ltd:
    1. Net Profit Margin: 43.30%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 19.28% (Industry Average ROCE: %)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: 14.67% (Industry Average ROE: %)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): 259.05
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 6.56
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. Stock P/E: 27.5 (Industry average Stock P/E: )
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. Total Debt / Equity: 0.00
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
    Stock Rating:

About the Company

Kilpest India Ltd. is a Public Limited Listed company incorporated on 27/05/1972 and has its registered office in the State of Madhya Pradesh, India. Company’s Corporate Identification Number(CIN) is L24211MP1972PLC001131 and registration number is 001131. Currently Company is involved in the business activities of Manufacture of pesticides and other agrochemical products. Company’s Total Operating Revenue is Rs. 15.52 Cr. and Equity Capital is Rs. 7.49 Cr. for the Year ended 31/03/2022.
INDUSTRYADDRESSCONTACT
Agro Chemicals/Pesticides7-C, Industrial Area, Govindpura, Bhopal Madhya Pradesh 462023kilpestbpl@yahoo.co.in
http://www.kilpest.com
Management
NamePosition Held
Mr. Dhirendra DubeyChairman & Managing Director
Mr. N K DubeyWholeTime Director & CFO
CA. Shabbar HusainIndependent Director
Mr. Abdul Moin KhanIndependent Director
Mrs. Mithala DubeyDirector
Mr. Harihar Prasad ThapakIndependent Director

FAQ

What is the latest fair value of 3B Blackbio DX Ltd?

The latest fair value of 3B Blackbio DX Ltd is ₹1168.25.

What is the Market Cap of 3B Blackbio DX Ltd?

The Market Cap of 3B Blackbio DX Ltd is 884 Cr..

What is the current Stock Price of 3B Blackbio DX Ltd as on 21 July 2024?

The current stock price of 3B Blackbio DX Ltd as on 21 July 2024 is 1,030.

What is the High / Low of 3B Blackbio DX Ltd stocks in FY 2024?

In FY 2024, the High / Low of 3B Blackbio DX Ltd stocks is 1,274/420.

What is the Stock P/E of 3B Blackbio DX Ltd?

The Stock P/E of 3B Blackbio DX Ltd is 27.5.

What is the Book Value of 3B Blackbio DX Ltd?

The Book Value of 3B Blackbio DX Ltd is 260.

What is the Dividend Yield of 3B Blackbio DX Ltd?

The Dividend Yield of 3B Blackbio DX Ltd is 0.24 %.

What is the ROCE of 3B Blackbio DX Ltd?

The ROCE of 3B Blackbio DX Ltd is 21.0 %.

What is the ROE of 3B Blackbio DX Ltd?

The ROE of 3B Blackbio DX Ltd is 16.3 %.

What is the Face Value of 3B Blackbio DX Ltd?

The Face Value of 3B Blackbio DX Ltd is 10.0.

About the Author

Author Avatar
Getaka

Getaka, CFA, a financial analyst with 15 years of experience in the industry. Getaka holds an MBA degree and the Chartered Financial Analyst designation, demonstrating his profound understanding of financial analysis and investment management. Throughout his career, he has conducted numerous financial analyses and due diligence processes for companies in the industry, and has a strong track record of identifying key trends and opportunities. He leverages his expertise to deliver a thorough financial analysis of a company, encompassing its financial performance, key ratios, future prospects, and risks. Getaka is committed to providing accurate, reliable, and trustworthy information to help readers make informed decisions about their finances and investments.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in 3B Blackbio DX Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE